New Organometallic Ru(II) Compounds with Lonidamine Motif as Antitumor Agents

The combination of one molecule of organic and metal-based fragments that exhibit antitumor activity is a modern approach in the search for new promising drugs. In this work, biologically active ligands based on lonidamine (a selective inhibitor of aerobic glycolysis used in clinical practice) were...

Descripción completa

Detalles Bibliográficos
Autores principales: Shutkov, Ilya A., Okulova, Yulia N., Mazur, Dmitrii M., Melnichuk, Nikolai A., Babkov, Denis A., Sokolova, Elena V., Spasov, Alexander A., Milaeva, Elena R., Nazarov, Alexey A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223346/
https://www.ncbi.nlm.nih.gov/pubmed/37242608
http://dx.doi.org/10.3390/pharmaceutics15051366

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223346/
https://www.ncbi.nlm.nih.gov/pubmed/37242608
http://dx.doi.org/10.3390/pharmaceutics15051366

Ejemplares similares